PBM Pharmaceutical Investor Relations
At PBM Pharmaceutical we believe that someone’s health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated and cured, treatments are smarter and less invasive and solutions are personal.
Corporate Profile
PBM Pharmaceutical is building a leading, diversified healthcare company committed to improving the lives of people living with serious medical conditions. We are growing our portfolio of differentiated medications to treat serious medical conditions. We are proud of our leadership in responsible pain management, with a portfolio of products addressing severe and persistent pain, and our expansion into neurology with the purpose of in-house practice dispensing. Each of our products represents meaningful innovation and together reflect our commitment to leadership across indications for the benefit of patients and their physicians.
If you have questions from our Investor Relations department, please email PBM Pharmaceutical at contact@pbm-pharma.com.
Our Approach to Investor Relations
Six key points shape how we engage with the financial community—delivering clear, credible, and consistent communication at every step.
Transparent
Communicate openly and thoroughly, sharing both successes and setbacks to build trust through honesty and clarity.
Credible
Set realistic expectations, deliver on our promises, and take accountability—we foster confidence even when outcomes are challenging.
Consistent
Manage expectations carefully, ensuring stakeholders know what information to expect, when to expect it, and how it will be delivered.
Accessible
Prioritize timely, detailed responses to inquiries, ensuring all audiences are properly supported.
Proactive
Maintain ongoing, meaningful engagement with stakeholders, reaching out regularly to build and strengthen relationships.
Integrated
Align communications across internal teams to deliver consistent, connected messages to all external audiences.
Get in Touch With Us
Fill out the contact form below, and a member of our team will reach out shortly.
How We Create Value in Healthcare
Our values enable us to carry out our mission of building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions.
Insights Gathering
Support strategic decision-making through targeted insight gathering across the product life cycle. From KOL identification and advisory boards to competitive intelligence and launch readiness, our approach helps uncover the perspectives that shape smarter planning, stronger differentiation, and more impactful engagement.
Evidence Generation & Life Cycle Management
Develop comprehensive evidence generation plans that support differentiation and access. Our approach considers the full spectrum of clinical and real-world evidence needed to engage clinicians, payers, and patients—supported by gap analyses, steering committees, and life cycle planning.
Realizing our values
PBM Pharmaceutical’s core values are foundational beliefs that are shared by each member of our team. We are passionate about applying them to all facets of our healthcare business, corporate social responsibility (CSR) commitments and working relationships with each other and our customers.
Science Powered by Storytelling
At PBM Pharmaceutical, we translate complex clinical data into clear, high-impact communications and education across the product life cycle. With deep scientific expertise, flawless execution, and a strong track record, we deliver the strategic insights needed to engage and activate key audiences. From scientific platforms to disease education, publications, and medical content, we bring science and data to life.
Scientific Narrative & Platform Development
Through a collaborative process with internal teams, we develop succinct, cross-functional scientific narratives grounded in referenced data and shaped by external insights and the current treatment landscape. Our platforms support communication planning, literature gap analyses, publication strategy, and scientific content development.